<?xml version="1.0" ?>
<document id="28755528">
  <sentence id="28755528.s0" text="Triple-negative breast cancer (TNBC), lacking the steroid hormone receptors ER and PR and the oncoprotein signal transduction, is characterized by its aggressive pattern and insensitivity to endocrine and HER2-directed therapy.">
    <entity charOffset="23-29" id="28755528.s0.e0" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <entity charOffset="106-125" id="28755528.s0.e1" ontology_id="GO_0007165" text="signal transduction" type="GO"/>
    <pair e1="28755528.s0.e0" e2="28755528.s0.e1" id="28755528.s0.p0" relation="true"/>
  </sentence>
  <sentence id="28755528.s1" text="amelogenesis protein is localized in the cytoplasm of tumor and stroma cells.">
    <entity charOffset="0-12" id="28755528.s1.e0" ontology_id="GO_0097186" text="amelogenesis" type="GO"/>
    <entity charOffset="54-59" id="28755528.s1.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="28755528.s1.e0" e2="28755528.s1.e1" id="28755528.s1.p0" relation="true"/>
  </sentence>
  <sentence id="28755528.s2" text="In this patient cohort, elevated stroma cell amelogenesis expression, but not tumor cell KLK4 expression, is predictive for poor disease-free survival by univariate analysis (hazard ratio: 2.26, p=0.001) and multivariable analysis (hazard ratio: 2.12, p&amp;lt;0.01).">
    <entity charOffset="45-57" id="28755528.s2.e0" ontology_id="GO_0097186" text="amelogenesis" type="GO"/>
    <entity charOffset="78-83" id="28755528.s2.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="28755528.s2.e0" e2="28755528.s2.e1" id="28755528.s2.p0" relation="true"/>
  </sentence>
</document>
